1. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies;Bhujbal;Acta Pharm. Sin. B,2021
2. Application of spray-drying and electrospraying/electospinning for poorly water-soluble drugs: a particle engineering approach;Bohr;Curr Pharm Des,2014
3. Bruker. 2024. 'Application Report XRD 32, D8 Discover Plus, Lower Limits of Detection (LOD) and Quantification (LOQ) for Respirable Silica', Accessed 15th March. https://my.bruker.com/acton/attachment/2655/f-0e17/1/-/-/-/-/XRD%20D8%20DISCOVER%20plus%20POWER%20LOD%20Application%20Report%20DOC-R88-EXS032_high.pdf#:∼:text=XRD%20Limit%20of%20Quantification%20%28LOQ%29%20defines%20the%20lowest,should%20consider%20the%20slope%20of%20the%20calibration%20curve.
4. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic;Butreddy;Eur. J. Pharm. Biopharm.,2022
5. The biopharmaceutics classification system (BCS) and the biopharmaceutics drug disposition classification system (BDDCS): Beyond guidelines;Charalabidis;Int J Pharm,2019